Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors. by Karimi, Mehrdad. et al.
PSYCHIATRY
ORIGINAL RESEARCH ARTICLE
published: 07 April 2014
doi: 10.3389/fpsyt.2014.00023
Drug injection to sites other than arm: a study of Iranian
heroin injectors
Mehrdad Karimi 1, Hafez Ghaheri 2, Shervin Assari 3, Khodabakhsh Ahmadi 4, Maryam Moghani Lankarani 5,
Reza Moghani Lankarani 6, Hooman Narenjiha7, Hassan Rafiey 7, MahmoodTavakoli 7* and Firoozeh Jafari 7
1 Shahrekord University of Medical Sciences, Tehran, Iran
2 Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI, USA
4 Behavioral Sciences Research Center, Baqiyatallah Medical Sciences University, Tehran, Iran
5 Universal Network for Health Information Dissemination and Exchange, Tehran, Iran
6 Medicine and Health Promotion Institute, Tehran, Iran
7 Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
Edited by:
Mohammadreza Mokhtari, Institute of
Living – Hartford Hospital, USA
Reviewed by:
Angelo Giovanni Icro Maremmani,
University of Pisa, Italy
Mohammadreza Mokhtari, Institute of
Living – Hartford Hospital, USA
Masoumeh Dejman, University of
Social Welfare and Rehabilitation
Sciences, Iran
*Correspondence:
MahmoodTavakoli , Substance Abuse
and Dependence Research Center,
University of Social Welfare and
Rehabilitation Sciences, Koodak-yar
Ave Daneshjoo Blvd., EvinTehran, Iran
e-mail: tavackoli@hotmail.com
For almost all injecting drug users (IDUs), the first site of injection is the arm. Years
after injection, IDUs may shift to using other sites for intravenous (IV) access. Although
injection to sites other than the arm is associated with higher risks, literature is limited
regarding this behavior. We aimed to determine the prevalence and associated factors
of using IV access points other than the arm among a national sample of IDUs in Iran.
Data came from the National Drug Dependence Survey, 2007, which had enrolled 863
IDUs with at least one daily injection. Data on socio-demographics, pattern of drug use,
and injection-related behaviors were entered into a logistic regression to determine pre-
dictors of injection to sites other than the arm. From all participants, 54.8% reported
current injection sites in areas other than the arm. The other injection sites were the
femoral venous sinus (17.0%), followed by the groin (14.5%) and neck (11.5%). Logistic
regression revealed that living alone [odds ratio (OR)=1.789, 95% confidence interval
(CI)=1.218–2.629], being Sunni (OR=3.475, 95% CI=1.775–6.801), having higher family
income (OR=1.002, 95% CI=1.001–1.003), higher age at first drug use (OR=1.039, 95%
CI=1.009–1.069), longer injection duration (OR= 1.071, 95% CI=1.041–1.102), and more
injection frequency (OR=1.255, 95% CI=1.072–1.471) were associated with higher like-
lihood of using injection sites other than the arm. Using sites other than the arm for IV
injection is linked to socio-demographics, drug use data, and injection-related characteris-
tics that can be used by policy makers. This information can be used for harm reduction
planning.
Keywords: drug injection, injection sites, arm, Iran, heroin
INTRODUCTION
Intravenous (IV) access points can develop several local compli-
cations that may involve skin or vascular structure (1–9). These
complications vary in severity from a simple erythema and pain, to
necrosis, thrombophlebitis, vein sclerosis, and occlusion. Follow-
ing these complications, injecting drug users (IDUs) show interest
in using other IV access points from an unusable vein to a new
useable one (10, 11). Detailed information on IV access points
increases our knowledge about IDUs’ high-risk behaviors. Clini-
cians, public health practitioners, and policy makers may use such
information to protect the health of IDUs.
Although we know that first injections often begin in the arm as
the primary point for IV access (10), there is lack of knowledge on
trajectory of IDUs in using different IV access points. According
to the current literature, most IDUs begin their injecting practice
using the arm and then gradually shift to other sites including
forearm, upper arm, hand, neck, feet, leg, and femoral vein. Some
researchers regard IV access point as a measure of the severity of
problems of IDUs (11).
The purpose of this study was to determine prevalence and
associated factors of non-arm injection among Iranian IDUs using
heroin.
MATERIALS AND METHODS
DESIGN AND SETTING
Data came from the National Drug Dependence Survey that was
conducted in 2007 and used a cross-sectional design. The main
survey had a sample size of 7,743 performed by the research cen-
ter for substance abuse and dependence at the University of Social
Welfare and Rehabilitation Sciences. Some other manuscripts have
been published from this database (12, 13).
PARTICIPANTS AND SAMPLING
The participants were substance-dependent adults according to
the DSM-IV. Participants were sampled from treatment centers
(n= 1,217), prisons (n= 584), or streets (n= 5,860) from the
capitals of 29 provinces in Iran. The sampling strategy in treat-
ment centers and prisons was random, but snowball in streets.
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The number of samples taken from every province was propor-
tional to the population of the province. The sampling started in
April 2007 and lasted for 5 months.
PROCESS
The interviews were carried out by university graduates (MS, BS)
with drug abuse-related majors/degrees who were dispatched to
the provinces after being trained through workshops in Tehran
(the capital of the Islamic Republic of Iran). Each interview took
60–90 min. Data were collected using a paper-based questionnaire
that was the modified version of the one used in the previous
national survey in Iran (14). The questionnaire included 69 items
in nine sections.
SECONDARY ANALYSIS
This study used a sample of all 863 IDUs with at least once daily
heroin injections for 1 year. Participants were all heroin users with
at least once daily heroin injections. We entered the following
data into our analysis: socio-economic data, drug use pattern, and
injection-related data.
OUTCOME
“Injection to other sites than arm”was determined by the following
question: To which site do you often inject? Responses included
the femoral venous sinus, groin, neck, and other sites.
CODES OF ETHICS
The study was approved by the ethical review committee of the
University of Social Welfare and Rehabilitation Sciences. Informed
consent was obtained from all the participants after they had been
verbally reassured that the information would be kept confidential,
especially from the correctional system.
STATISTICAL ANALYSIS
Data were analyzed in the SPSS for Windows 13 statistical
package. Continuous variables were described using mean and
standard deviation (SD) or median (percentile 25%=Q1 and
percentile 75%=Q3). In order to determine the association
between independent variables and outcome (injection to sites
other than the arm), the χ2 test, independent samples t test
and Mann–Whitney were used. Logistic regression was used for
multivariable analysis. Odds ratios (ORs), with 95% confidence
intervals (CIs) were reported. P-value <0.05 was considered
significant.
RESULTS
DEMOGRAPHICS AND DRUG-RELATED DATA
From the total 863 IDUs who were enrolled into this study, most
participants were mostly men, Muslim, and had started drug use
with opioids (Table 1).
Participants had a mean age of 31.7± 8.6 years. First drug use
and injection had begun at 18.1± 5.3 and 25.7± 6.6, respec-
tively. Injection duration was 6.0± 5.9 years. Mean income and
drug payment were US $ 306.0 (835.3) and US $ 218.9 (300.5),
respectively.
Table 1 | Socio-demographic, drug related, and drug problems among
IDUs (n=863).
n %
SAMPLING PLACE
Street 693 80.3
Prison 59 6.8
Treatment centers 101 11.7
Missed 10 1.2
SAMPLING PROVINCE
Tehran 206 23.9
Khorasan 66 7.6
Guilan 63 7.3
Yazd 61 7.1
Lorestan 48 5.6
Hamedan 40 4.6
Kordestan 35 4.1
Fars 34 3.9
Hormozgan 32 3.7
Others 278 32.2
SOCIO-DEMOGRAPHIC DATA
Gender
Men 835 96.8
Women 25 2.9
Missed 3 0.3
Religion
Islam 849 98.4
Shia 797 92.4
Sunni 52 6.0
Other religions 1 0.1
Missed
Unemployed 371 43.0
Employed 0 0
Missed
Living alone
With others 688 79.7
Alone 175 20.3
Missed 0 0
DRUG USE DATA
First drug of abuse
Cannabis 289 33.5
Opium or its derivates 296 34.3
Heroin 97 11.2
Amphetamines 2 0.2
Others 173
Current dominant drug
Powder heroin 498 57.7
Crystal heroin 365 42.3
Years injection
1–4 459 53.2
5–9 220 25.5
10–14 105 12.1
15–19 40 4.7
20 and more 30 3.1
Monthly injection frequency
3 times or less 24 2.8
4–30 times 64 7.4
31–60 times 104 12.1
61–90 times 428 49.6
90 times or more 243 28.2
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Table 2 | Regressors of non-arm injection among Iranian IDUs (n=863).
Characteristics B SE Wald df Sig. Exp(B) 95% CI for EXP(B)
Lower Upper
Living status (alone) 0.582 0.196 8.781 1 0.003 1.789 1.218 2.629
Islam type (Sunni) 1.245 0.343 13.210 1 0.000 3.475 1.775 6.801
Family income ($ US) 0.001 0.000 7.367 1 0.007 1.001 1.000 1.001
Age at first use (years) 0.038 0.015 6.572 1 0.010 1.039 1.009 1.069
Injection duration (years) 0.069 0.014 22.713 1 <0.001 1.071 1.041 1.102
Past year injection frequency 0.227 0.081 7.939 1 0.005 1.255 1.072 1.471
INJECTION TO OTHER SITES
Sites other than the arm were reported to be the site of injec-
tion among 54.8% of IDUs (n= 473). Injection sites included
the groin (n= 125; 14.5%), neck (n= 99; 11.5%), femoral venous
sinus (n= 147; 17.0%), and others (n= 26, 3.0%).
Based on our bivariate analysis, being Sunni (OR= 1.406, 95%
CI= 1.187–1.667) and living alone (OR = 1.218, 95% CI= 1.057–
1.403) were associated with higher likelihood of non-arm injec-
tion. Although men had a higher rate of non-arm injection than
women, this difference was not significant (OR= 1.540, 95%
CI= 0.910–2.607).
Logistic regression revealed that living alone (OR= 1.789, 95%
CI= 1.218–2.629), being Sunni (OR= 3.475, 95% CI= 1.775–
6.801), higher family income (OR= 1.002, 95% CI= 1.001–
1.003), higher age at first use (OR= 1.039, 95% CI= 1.009–1.069),
longer injection duration (OR= 1.071, 95% CI= 1.041–1.102),
and more injection frequency (OR= 1.255, 95% CI= 1.072–
1.471) were associated with an increased likelihood of injection
to IV access points other than the arm (Table 2).
DISCUSSION
More than half of Iranian male IDUs use IV access points other
than the arm. Logistic regression revealed that likelihood of other
IV access points other than the arm was increased by some
socio-economic characteristics such as living alone (OR= 1.789),
being Sunni (OR= 3.475), and higher family income ($ US)
(OR= 1.002). Drug-related data such as higher age at first drug
use (OR= 1.039), and injection-related data such as more injec-
tion duration (OR= 1.071) and injection frequency (OR= 1.255)
were also linked to this behavior.
From the above list of factors, the effect of injection duration
and injection frequency on likelihood of shifting to other sites of
injection was expected, as shift in IV access point occurs as drug
injection progresses. That is, the shift in site of drug use may be a
part of the natural history of drug injection. However, in the very
limited pool of published evidences about pattern of IV access
points, we could not find any evidence confirming or rejecting our
findings about the association of being Sunni, family income, age
at first drug use, or our outcome.
In contrast to our expectations, and opposite to the literature
that emphasizes the role of low socio-economic status as a risk
factor of poor health (15–18) and health risk behaviors (19, 20),
our study suggested that IDUs with higher family income may be
at higher risk of shifting to using other IV access points.
Different from most of the literature, it was not lower age
at first drug use (21, 22) but higher age at first drug use that
was associated with higher risk of shifting from the arm to
another injection site. Similar to our findings, one study on 144
IDUs with ≤5 years of injection use reported that adolescent-
initiating IDUs were less likely to report high-risk sex and injection
behaviors than adult-initiating IDUs (23). Baldwin et al. (24)
reviewed the literature and hypothesized that early initiation of
substance use may be associated with a pattern of maladap-
tive coping mechanisms in which the substance is implemented
to manage stress (25). Heavy drug use, during a critical period
of neurobiological development, may also lead to dysfunction
in memory and learning, inhibition, and executive functioning
and neuronal activation, or even ultimately alterations in brain
structure (26).
The use of injection sites other than the arm among IDUs is a
major public health concern. Such behaviors are often associated
with an increased risk of vascular complications such as deep vein
thrombosis, leg ulcers, and vascular insufficiency. In addition, in
some sites such as the groin and neck, the close proximity to other
organs poses the risk of inadvertent trauma to these sites (27).
Unfortunately, data is systematically scarce in this regard (10).
Some years after first injection (10), IDUs may have some
concerns about difficulty of injection in previous injection sites,
and worry about the risk of loss of the injection/hit. In this
stage, other sites might be seen by an IDU as “easy-to-use” with
more secure delivering of the injection intravenously (10). An
IDU may show interest in using other points for IV access, as a
result (11).
Within non-arm injection sites, the most frequent site was the
groin. According to the literature, among heroin IDUs, groin injec-
tion seems convenient, providing quick access, with little mess
and less pain than smaller more awkward veins. The formation of
sinuses over time facilitates continued use of the groin (10).
According to our findings, likelihood of non-arm injection
increases by an increase in injection duration. Literature con-
firms that most IDUs begin to use other injection sites years
after their first injection (10). According to a study, IDUs shift
to injection in the forearm in 2 years, shift to injection in the
upper arm in 3.5 years, shift to injection in the hand, neck, feet,
and leg in 4 years, and shift to injection in the groin 10 years
after their first injection (11). Injectors decide to shift to a new
injection site when they believe the previous site is no longer
accessible (10).
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Based on harm reduction protocols, practices such as the rota-
tion of injecting sites may prevent scar tissue occlusion, swelling,
infections, and deep vein thrombosis among IDUs. In addition,
literature cites that IDUs believe that this rotation is both difficult
and unreliable. The rotation of injecting to both arms needs using
non-dominant hands, which might seem problematic to IDUs.
Secondary to this perceived difficulty, IDUs find other IV access
points as convenient, providing quick access, with little mess and
less pain than previously used arm veins (10).
Non-arm injection is of interest because it is linked to high
rates of local complications including tissue damage, infections,
and deep venous thrombosis (10, 11). Our recommendation to
service providers is that site of injection is an important factor
that should be asked about when a service is being delivered to an
IDU. Harm reduction services in Iran should include safe injecting
trainings for IDUs.
This study sheds more light on the risk factors of transition to
more severe injection sites. Of the factors, injection frequency and
living status are modifiable, and can be considered as the target of
prevention programs. Injecting to sites such as the femur or neck
should be strongly discouraged, because of the associated health
hazards. These veins are at proximity of vital arteries. Missing the
aimed vein may result in hitting the artery or nerves, which may
cause major health problems for the IDU (28, 29). Promotion of
safe injection should be considered as a part of harm education
programs, and may encourage the practice of safe injection among
IDUs. Such training programs can be delivered as a part of needle
exchange programs.
Safe injecting education programs may benefit from informa-
tion about the motivations for transitioning to new IV access
points. We do not know whether training programs that enhance
safe injection information among IDUs will increase the use of
peripheral veins and decrease the use of risky injection sites such
as neck and groin. IDUs should not be encouraged to use others for
injection or injection facilitation, as presence of other IDUs at the
time of injection may increase the risk of shared injection, which
is linked to risk of blood-borne infections such as HIV. However,
IDUs should receive information on health risks associated with
transition to other access points for injections.
Not only may the findings of this research be of interest to
the policy makers in Iran, but they may also benefit the global
harm reduction community. Groin injecting is a neglected topic.
Similar studies will shed more light on factors that are linked to
similar practices among IDUs. Information provided by this study
is hoped to be used for the development of evidence-based safe
injecting advice.
LIMITATION
Although Iran is a country that includes multiple ethnicities with
unique cultures, we did not enter ethnicity to our analysis. Some
participants were sampled using a snowball strategy, thus the
results are not generalizable to all Iranian male IDUs. This study
did not enquire data on the pattern of transition between different
injection sites. The study only included heroin users, thus fur-
ther research is needed on individuals who inject drugs other than
heroin. This study had a retrospective design. Longitudinal stud-
ies are still required. Further work is needed to better understand
the natural history of IDUs, especially their pattern of shift in IV
access points.
CONCLUSION
This study found that half of Iranian male IDUs report injection
to IV accesses points other than the arm. This behavior is attached
to some socio-economic and drug-related characteristics. Infor-
mation on factors associated with non-arm injection may be used
for evidence-based harm reduction practice.
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